The role of estrogens and related compounds in the management of primary hyperparathyroidism.

Robert Marcus

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;17 Suppl 2():N146-9

PMID: 12412792

View on PubMed

Abstract

Address: USMD Endocrinology, Eli Lilly Corporation, Indianapolis, Indiana 46221-2001, USA.

MeSH Terms: Bone Density, Calcium, Estrogens, Humans, Hyperparathyroidism, Parathyroid Hormone, Raloxifene Hydrochloride, Selective Estrogen Receptor Modulators

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.